1Ito H, Tomooka T,Sakai N, et al. Lack of myocardial perfusion immediately after successful thrombolysis. A predictor of poor recovery of left ventricular function in anterior myocardial infarction [J]. Circulation, 1992,85(5) : 1699-1705.
2Stone G,Grines C,Cox D,et al. Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infaretion[J]. N Engl J Med,2002,346(13) :957-966.
3Antman E,Cohen M,Bernink P, et al. The TIMI risk score for unstable angina/non-ST elevation MI : method for prognostication and therapeutic decision making[J]. JAMA, 2000,284(7) :835-842.
4Morrow D, Antman E, Snapinn S, et al. An integrated clinical approach to predicting the benefit of tirofiban in non-ST elevation acute coronary syndromes. Application of the TIMI Risk Score for UA/NSTEMI in PRISM-PLUS[J]. Eur Heart J, 2002.23(3):223-229.
5Bolognese L, Falsini G, Liistro F, et al. Randomized comparison of upstream tirofiban versus downstream high bolus dose tirofiban or abeiximab on tissue-level perfusion and troponin release in high-risk acute coronary syndromes treated with percutaneous coronary interventions: the EVEREST Trial[J]. J Am Coll Cardiol,2006,47(3) :522-528.
6Henriques J, Zijlstra F, Ottervanger J, et al. Incidence and clinical significance of distal embolization during primary angioplasty for acute myocardial infarction[J]. Eur Heart J, 2002,23(14):1112-1117.
7Lincoff A. Trials of platelet glyeoprotein Ⅱ b/Ⅲ a receptor antagonists during percutaneous coronary revascularization[J]. Am J Cardiol,1998,82(8) :36-42.
1Naruko T, Ueda M, Haze K,et al. Neutrophil infiltration of cuoprit lesions in acute coronary syndromes[ J]. Circulation, 2002, 106 ( 23 ) :2894-2900.
2Azar R, Badaoui G, Sarkis A, et al. Effects of tirofiban and statins on high sensiitivity Creactive protein, interleukin-6, and soluble CD40 ligand following percutaneous coronary interventions in patients with stable coronary artery dlsease[J]. Am J Cardiol, 2005, 95(2) :236-240.
3Stone GW, Grines CL, Cox DA, et al. Comparision of angioplasty with stenting, with or without abciximab, in acute myocardial infarction[J]. N Eng J Med, 2002,346(13):957-966.
